Advertisement.

Hilary Kramer

share

Cannabis stocks went on a big circular ride this week, ultimately ending up roughly where they started. I am not concerned, but I’m not especially thrilled either. Tilray Inc. (NASDAQ:TLRY), for example, soared 150% early in the week, only to drop a harrowing 56% in the last two days. Other Big Green stocks like Canopy […]

share

If you blinked, you missed it. Corporate profits have nudged back above the level we saw a year ago. The growth trend is back, alive and well. That’s a real achievement. Through all the shocks we’ve absorbed in the past 12 months, companies on the S&P 500 are now making more money than they were […]

share

This has been a seminal week for the cannabis stocks. What’s remarkable is how few Wall Street commentators are able to connect the right dots. The group of 12 companies I track in this space surged another 22% this week. Several, including the transformed Tilray Corp. (NASDAQ:TLRY), gained up to twice that much ground. Some […]

share

The aftershocks from the recent day trader rampage are receding now, but the CBOE Volatility Index or “VIX” remains a little elevated from what I consider comfortable levels. In fact, the VIX hasn’t traded in normal statistical territory since Feb. 24, 2020, when COVID-19 cases started to bloom across the United States and the pre-pandemic […]

share

Wall Street’s dirty secret went public this week. Fundamentals don’t always matter. Human beings are irrational. Asset prices can bend the limits of statistics and common sense before cold logic takes over again. And once the market starts swinging like this, there’s not a lot of point in fighting the tide. Just ask the hedge […]

share

You only need to look to Big Cannabis to see the cracks in the “short squeeze” scenario.  While the giants in this space are often shorted, neither Aurora Cannabis Inc. (NYSE:ACB) nor Canopy Growth Corp. (NYSE:CGC) even rates near the top of the list. ACB, for example, is roughly as heavily shorted as Texas restaurant […]